These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3511127)

  • 1. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials.
    Spector SL; Kinsman R; Mawhinney H; Siegel SC; Rachelefsky GS; Katz RM; Rohr AS
    J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):65-70. PubMed ID: 3511127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study.
    Mann JS; Clement P; Sheridan AQ; Soryal I; Fairfax AJ; Holgate ST
    J Allergy Clin Immunol; 1985 Jul; 76(1):83-90. PubMed ID: 4008815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalation challenge with specific grass pollen antigens in asthmatics and the effect of lodoxamide tromethamine.
    Parrish RW; Davies BH
    Thorax; 1983 Jun; 38(6):458-62. PubMed ID: 6136101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of lodoxamide tromethamine on the immediate asthmatic response to allergen provocation.
    Ollier S; Graham VA; Bentley S; Davies RJ
    Clin Allergy; 1982 Nov; 12(6):587-94. PubMed ID: 7151268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
    Grutzmacher RD; Foster RS; Feiler LS
    Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm.
    Ungerer RG; Tashkin DP; Siegel SC; Deutsch RI
    J Allergy Clin Immunol; 1981 Dec; 68(6):471-8. PubMed ID: 7310012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
    Johnson HG; Sheridan AQ
    Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance in clinical trials of two nonbronchodilator, antiasthma medications.
    Mawhinney H; Spector SL; Kinsman RA; Siegel SC; Rachelefsky GS; Katz RM; Rohr AS
    Ann Allergy; 1991 Apr; 66(4):294-9. PubMed ID: 2014927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
    Watt GD; Bui TC; Bewtra AK; Townley RG
    J Allergy Clin Immunol; 1980 Oct; 66(4):286-94. PubMed ID: 7419830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the variance components in a pharmaceutical aerosol product: lodoxamide tromethamine.
    Havel HA; Beaubien LJ; Haaland PD
    J Pharm Sci; 1985 Sep; 74(9):978-82. PubMed ID: 4067853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metered-dose inhaler usage in subjects with asthma: comparison of Nebulizer Chronolog and daily diary recordings.
    Gong H; Simmons MS; Clark VA; Tashkin DP
    J Allergy Clin Immunol; 1988 Jul; 82(1):5-10. PubMed ID: 3392369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
    Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
    Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of lodoxamide and verapamil on antimicrobial action in vitro.
    McGregor JA; Levin MJ; Masters H
    J Infect Dis; 1986 Sep; 154(3):542-3. PubMed ID: 3734496
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of ischemia-reperfusion injury by the allergy drug lodoxamide tromethamine.
    Parenteau GL; Clark RE
    Ann Thorac Surg; 1991 Oct; 52(4):832-8. PubMed ID: 1929638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact lens induced conjunctivitis: a model of human ocular inflammation.
    Friedlaender MH
    CLAO J; 1996 Jul; 22(3):205-8. PubMed ID: 8828938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of lodoxamide in plasma using ion-pairing and reversed-phase high-performance liquid chromatography.
    Honigberg IL; Stewart JT; Ewing BJ; Taylor WD
    J Chromatogr; 1983 Aug; 276(1):213-7. PubMed ID: 6672016
    [No Abstract]   [Full Text] [Related]  

  • 17. Measuring compliance with inhaled medication in asthma.
    Coutts JA; Gibson NA; Paton JY
    Arch Dis Child; 1992 Mar; 67(3):332-3. PubMed ID: 1575560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lodoxamide tromethamine on paraplegia that occurs after infrarenal aortic occlusion in the rabbit.
    Ball TD; Lundy EF; Zelenock GB; D'Alecy LG
    J Vasc Surg; 1987 Dec; 6(6):572-7. PubMed ID: 3694755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis].
    Maĭchuk IuF; Khaitova KN; Grishakova MB
    Vestn Oftalmol; 1998; 114(4):43-4. PubMed ID: 9771090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nebulizer chronolog to monitor compliance with inhaler use.
    Tashkin DP; Rand C; Nides M; Simmons M; Wise R; Coulson AH; Li V; Gong H
    Am J Med; 1991 Oct; 91(4A):33S-36S. PubMed ID: 1951401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.